Stay updated on Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Sign up to get notified when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.

Latest updates to the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page’s footer now displays site revision v3.8.1 instead of v3.8.0.SummaryDifference0.2%

- Check9 days agoChange DetectedThe record for the Marzeptacog Alfa trial is displayed with its study design, participant criteria, treatment details, outcomes, and research locations. It indicates the study was terminated by company decision and is no longer recruiting participants.SummaryDifference48%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0 on a page showing a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedA site-wide banner announces NIH website updates and says that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check37 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check44 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1 while the page remained on a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Factor VIIa Marzeptacog in Bleeding Disorders Clinical Trial page.